IFNB1 and myeloid sarcoma: However, in 2010, van der Voort and colleagues reported that a group of NAb positive MS patients deteriorated more rapidly than expected over the following years, suggesting that the presence of IFNβ NAbs may in itself be a risk factor for MS progression by an unknown mechanism (20).